Call our 24 hours, seven days a week helpline at 800.272.3900

24/7 Helpline 800.272.3900
Donate

Alzheimer’s disease doesn’t stop — and neither do we.

The Alzheimer’s Association leads the way toward ending Alzheimer’s and all other dementia. Donate today so we can continue accelerating critical research and providing 24/7 support during this global emergency and beyond.

Give Now
Families Facing Alzheimer’s Need You Now More Than Ever

Alzheimer's Association Awards $4.3 Million to Accelerate Launch of New Drug Treatment Arms in Landmark Prevention Trial

Alzheimer's Association Awards $4.3 Million to Accelerate Launch of New Drug Treatment Arms in Landmark Prevention Trial
Share or Print this page
Share or Print this page
April 22, 2016
Email: media@alz.org
Share or Print this page

Alzheimer's Association Awards $4.3 Million to Accelerate Launch of New Drug Treatment Arms in Landmark Prevention Trial

The Alzheimer's Association announces a new $4.3 million research grant for a new phase of the Dominantly Inherited Alzheimer's Network Trials Unit (DIAN-TU) known as DIAN-TU Next Generation (NexGen). This award will accelerate the testing of new potential Alzheimer's therapies and a new diagnostic approach in people with genetically based, younger-onset Alzheimer's disease using an innovative trial design that is being applied to Alzheimer's for the first time.

Alzheimer's Association

The Alzheimer's Association leads the way to end Alzheimer's and all other dementia — by accelerating global research, driving risk reduction and early detection, and maximizing quality care and support. Our vision is a world without Alzheimer's and all other dementia.™ For more information, visit www.alz.org or call the 24/7 Helpline at 800.272.3900.

Keep Up With Alzheimer’s News and Events